Senescence aging, and malignant transformation mediated by p53 in mice lacking the Brcal full-length isoform

被引:227
|
作者
Cao, L [1 ]
Li, WM [1 ]
Kim, S [1 ]
Brodie, SG [1 ]
Deng, CX [1 ]
机构
[1] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
p53; p21; senescence; aging; tumorigenesis;
D O I
10.1101/gad.1050003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Senescence may function as a two-edged sword that brings unexpected consequences to organisms. Here we provide evidence to support this theory by showing that the absence of the Brca1 full-length isoform causes senescence in mutant embryos and cultured cells as well as aging and tumorigenesis in adult mice. Haploid loss of p53 overcame embryonic senescence but failed to prevent the adult mutant mice from prematurely aging, which included decreased life span, reduced body fat deposition, osteoporosis, skin atrophy, and decreased wound healing. We further demonstrate that mutant cells that escaped senescence had undergone clonal selection for faster proliferation and extensive genetic/molecular alterations, including overexpression of cyclin D1 and cyclin A and loss of p53. These observations provide the first in vivo evidence that links cell senescence to aging due to impaired function of Brcal at the expense of tumorigenesis.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 50 条
  • [1] Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
    Lars O Baumbusch
    Simen Myhre
    Anita Langerød
    Anna Bergamaschi
    Stephanie B Geisler
    Per E Lønning
    Wolfgang Deppert
    Irene Dornreiter
    Anne-Lise Børresen-Dale
    Molecular Cancer, 5
  • [2] Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
    Baumbusch, Lars O.
    Myhre, Simen
    Langerod, Anita
    Bergamaschi, Anna
    Geisler, Stephanie B.
    Lonning, Per E.
    Deppert, Wolfgang
    Dornreiter, Irene
    Borresen-Dale, Anne-Lise
    MOLECULAR CANCER, 2006, 5 (1)
  • [3] Molecular dynamics of the full-length p53 monomer
    Chillemi, Giovanni
    Davidovich, Pavel
    D'Abramo, Marco
    Mametnabiev, Tazhir
    Garabadzhiu, Alexander Vasilievich
    Desideri, Alessandro
    Melino, Gerry
    CELL CYCLE, 2013, 12 (18) : 3098 - 3108
  • [4] Characterization of full-length p53 aggregates and their kinetics of formation
    Julian, Linda
    Sang, Jason C.
    Wu, Yunzhao
    Meisl, Georg
    Brelstaff, Jack H.
    Miller, Alyssa
    Cheetham, Matthew R.
    Vendruscolo, Michele
    Knowles, Tuomas P. J.
    Ruggeri, Francesco Simone
    Bryant, Clare
    Ros, Susana
    Brindle, Kevin M.
    Klenerman, David
    BIOPHYSICAL JOURNAL, 2022, 121 (22) : 4280 - 4298
  • [5] Core domain interactions in full-length p53 in solution
    Veprintsev, DB
    Freund, SMV
    Andreeva, A
    Rutledge, SE
    Tidow, H
    Cañadillas, JMP
    Blair, CM
    Fersht, AR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (07) : 2115 - 2119
  • [6] Modeling and Simulation of Full-length p53 Tetramer Bound to DNA
    Demir, Ozlem
    Leong, Pek
    PROTEIN SCIENCE, 2014, 23 : 98 - 98
  • [7] Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
    Dearth, Lawrence R.
    Qian, Hua
    Wang, Ting
    Baroni, Timothy E.
    Zeng, Jue
    Chen, Stephanie W.
    Yi, Sun Young
    Brachmann, Rainer K.
    CARCINOGENESIS, 2007, 28 (02) : 289 - 298
  • [8] pRB, p53, p16INK4a senescence and malignant transformation
    Larsen, CJ
    BULLETIN DU CANCER, 2004, 91 (05) : 399 - 402
  • [9] Full-length p53 tetramer bound to DNA and its quaternary dynamics
    Ö Demir
    P U Ieong
    R E Amaro
    Oncogene, 2017, 36 : 1451 - 1460
  • [10] Full-length p53 tetramer bound to DNA and its quaternary dynamics
    Demir, Oe
    Ieong, P. U.
    Amaro, R. E.
    ONCOGENE, 2017, 36 (10) : 1451 - 1460